Dermapharm Holding Financials
| DMP Stock | 37.80 0.20 0.53% |
Dermapharm |
Understanding current and past Dermapharm Holding Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Dermapharm Holding's financial statements are interrelated, with each one affecting the others. For example, an increase in Dermapharm Holding's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Dermapharm Holding's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Dermapharm Holding SE. Check Dermapharm Holding's Beneish M Score to see the likelihood of Dermapharm Holding's management manipulating its earnings.
| Instrument | Germany Stock View All |
| Exchange | XETRA Stock Exchange |
| ISIN | DE000A2GS5D8 |
| Business Address | Lil-Dagover-Ring 7, Grnwald, |
| Sector | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.dermapharm.de |
| Phone | 49 89 6 41 86 0 |
You should never invest in Dermapharm Holding without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Dermapharm Stock, because this is throwing your money away. Analyzing the key information contained in Dermapharm Holding's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Dermapharm Holding Key Financial Ratios
Dermapharm Holding's financial ratios allow both analysts and investors to convert raw data from Dermapharm Holding's financial statements into concise, actionable information that can be used to evaluate the performance of Dermapharm Holding over time and compare it to other companies across industries.| Return On Equity | 0.38 | |||
| Return On Asset | 0.12 | |||
| Target Price | 56.3 | |||
| Beta | 1.2 | |||
| Z Score | 1.8 |
Dermapharm Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dermapharm Holding's current stock value. Our valuation model uses many indicators to compare Dermapharm Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dermapharm Holding competition to find correlations between indicators driving Dermapharm Holding's intrinsic value. More Info.Dermapharm Holding SE is rated # 2 in return on equity category among its peers. It also is rated # 2 in return on asset category among its peers reporting about 0.32 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Dermapharm Holding SE is roughly 3.16 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dermapharm Holding's earnings, one of the primary drivers of an investment's value.Dermapharm Holding Systematic Risk
Dermapharm Holding's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Dermapharm Holding volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Dermapharm Holding correlated with the market. If Beta is less than 0 Dermapharm Holding generally moves in the opposite direction as compared to the market. If Dermapharm Holding Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Dermapharm Holding is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Dermapharm Holding is generally in the same direction as the market. If Beta > 1 Dermapharm Holding moves generally in the same direction as, but more than the movement of the benchmark.
Dermapharm Holding December 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Dermapharm Holding help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Dermapharm Holding SE. We use our internally-developed statistical techniques to arrive at the intrinsic value of Dermapharm Holding SE based on widely used predictive technical indicators. In general, we focus on analyzing Dermapharm Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Dermapharm Holding's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.53 | |||
| Information Ratio | 0.0753 | |||
| Maximum Drawdown | 10.99 | |||
| Value At Risk | (2.35) | |||
| Potential Upside | 3.97 |
Additional Tools for Dermapharm Stock Analysis
When running Dermapharm Holding's price analysis, check to measure Dermapharm Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermapharm Holding is operating at the current time. Most of Dermapharm Holding's value examination focuses on studying past and present price action to predict the probability of Dermapharm Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermapharm Holding's price. Additionally, you may evaluate how the addition of Dermapharm Holding to your portfolios can decrease your overall portfolio volatility.